ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.55
-0.12 (-7.19%)
Open$1.70
Previous Close$1.67
Day High$1.71
Day Low$1.43
52W High$17.64
52W Low$1.25
Volume—
Avg Volume161.8K
Market Cap5.71M
P/E Ratio—
EPS$-22.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+539.4% upside
Current
$1.55
$1.55
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.69B | 14.22B | 1.01M |
| Net Income | -96,490,762 | -84,026,788 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -94,308,509 | -86,689,001 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |